Orgenesis Inc.
ORGSDelisted May 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001460602
Orgenesis Inc. was delisted on May 8, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 1 institution reported holding it in 13F filings for Q1 2025, worth $124.0K in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Orgenesis Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −1 vs. Q3 2022
- Shares held
- 2.22M
- −649.8K (−22.6%) vs. Q3 2022
- Total value
- $4.33M
- +$257.6K (+6.3%) vs. Q3 2022
- New holders
- 2
- 8 more added
- Sold out
- 3
- 6 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ORGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $20.8K |
| Q1 2026 | 1 | $30.4K |
| Q4 2025 | 1 | $7.59K |
| Q3 2025 | 1 | $50.6K |
| Q2 2025 | 1 | $74.7K |
| Q1 2025 | 1 | $124.0K |
| Q4 2024 | 1 | $95.7K |
| Q3 2024 | 12 | $958.5K |
| Q2 2024 | 20 | $1.31M |
| Q1 2024 | 18 | $1.82M |
| Q4 2023 | 21 | $1.10M |
| Q3 2023 | 22 | $1.37M |
| Q2 2023 | 23 | $3.93M |
| Q1 2023 | 21 | $3.15M |
| Q4 2022 | 21 | $4.33M |
| Q3 2022 | 23 | $4.15M |
| Q2 2022 | 22 | $7.07M |
| Q1 2022 | 23 | $10.2M |
| Q4 2021 | 27 | $8.78M |
| Q3 2021 | 28 | $15.5M |
| Q2 2021 | 34 | $17.8M |
| Q1 2021 | 40 | $30.0M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Orgenesis Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 95 | $0 | 0.00% | −4−4.0% | Reduced |
| BNP Paribas Arbitrage, SA | 75 | $146 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 162 | $316 | 0.00% | +9+5.9% | Added |
| Bank of America Corp | 260 | $506 | 0.00% | −286−52.4% | Reduced |
| TSFG, LLC | 1,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,859 | $11.4K | 0.00% | +2,919+99.3% | Added |
| Morgan Stanley | 6,480 | $12.6K | 0.00% | −278−4.1% | Reduced |
| Barclays PLC | 6,880 | $13.4K | 0.00% | −20−0.3% | Reduced |
| Tower Research Capital LLC (TRC) | 11,793 | $23.0K | 0.00% | +2,099+21.7% | Added |
| Citadel Advisors LLC | 15,319 | $29.9K | 0.00% | +15,319 | New |
| Chapin Davis, Inc. | 20,000 | $39.0K | 0.02% | +20,000 | New |
| Prudential Financial Inc | 24,950 | $48.7K | 0.00% | +5,600+28.9% | Added |
| Bank Hapoalim BM | 32,052 | $63.0K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 36,227 | $70.6K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 36,409 | $71.0K | 0.00% | +12,000+49.2% | Added |
| Renaissance Technologies LLC | 47,499 | $93.0K | 0.00% | −3,500−6.9% | Reduced |
| State Street Corp | 88,659 | $172.9K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 120,562 | $235.1K | 0.00% | +117+0.1% | Added |
| Geode Capital Management, LLC | 206,754 | $403.0K | 0.00% | +7,198+3.6% | Added |
| Knoll Capital Management, LLC | 634,738 | $1.24M | 2.79% | −681,626−51.8% | Reduced |
| Vanguard Group Inc | 924,806 | $1.80M | 0.00% | +4550.0% | Added |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −29,269−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −165−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −334−100.0% | Sold out |
| Ronit Capital LLP | – | – | – | – | Not filed |